A randomized Phase III study of doxorubicin versus cisplatin/interferon alpha-2b/Docorubicin/Fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma

W Yeo; TS Mok; B Zee; TWT Leung; PBS Lai; WY Lau; J Koh; FKF Mo; SCH Yu; AT Chan; P Hui; B Ma; KC Lam; WM Ho; HT Wong; A Tang; Philip Johnson

doi:10.1093/jnci/dji315

A randomized Phase III study of doxorubicin versus cisplatin/interferon alpha-2b/Docorubicin/Fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma

W Yeo, TS Mok, B Zee, TWT Leung, PBS Lai, WY Lau, J Koh, FKF Mo, SCH Yu, AT Chan, P Hui, B Ma, KC Lam, WM Ho, HT Wong, A Tang, Philip Johnson

Cancer Research UK Clinical Trials Unit

Research output: Contribution to journal › Article

497 Citations (Scopus)

Original language	English
Pages (from-to)	1532-1538
Number of pages	7
Journal	Journal of the National Cancer Institute
Volume	97
DOIs	https://doi.org/10.1093/jnci/dji315
Publication status	Published - 19 Oct 2005

Access to Document

10.1093/jnci/dji315

Cite this

Yeo, W., Mok, TS., Zee, B., Leung, TWT., Lai, PBS., Lau, WY., Koh, J., Mo, FKF., Yu, SCH., Chan, AT., Hui, P., Ma, B., Lam, KC., Ho, WM., Wong, HT., Tang, A., & Johnson, P. (2005). A randomized Phase III study of doxorubicin versus cisplatin/interferon alpha-2b/Docorubicin/Fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma. Journal of the National Cancer Institute, 97, 1532-1538. https://doi.org/10.1093/jnci/dji315

@article{2581c09add7842cfafa3cf27a6e34195,

title = "A randomized Phase III study of doxorubicin versus cisplatin/interferon alpha-2b/Docorubicin/Fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma",

author = "W Yeo and TS Mok and B Zee and TWT Leung and PBS Lai and WY Lau and J Koh and FKF Mo and SCH Yu and AT Chan and P Hui and B Ma and KC Lam and WM Ho and HT Wong and A Tang and Philip Johnson",

year = "2005",

month = oct,

day = "19",

doi = "10.1093/jnci/dji315",

language = "English",

volume = "97",

pages = "1532--1538",

journal = "Journal of the National Cancer Institute",

issn = "1460-2105",

publisher = "Oxford University Press",

}

Yeo, W, Mok, TS, Zee, B, Leung, TWT, Lai, PBS, Lau, WY, Koh, J, Mo, FKF, Yu, SCH, Chan, AT, Hui, P, Ma, B, Lam, KC, Ho, WM, Wong, HT, Tang, A & Johnson, P 2005, 'A randomized Phase III study of doxorubicin versus cisplatin/interferon alpha-2b/Docorubicin/Fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma', Journal of the National Cancer Institute, vol. 97, pp. 1532-1538. https://doi.org/10.1093/jnci/dji315

TY - JOUR

T1 - A randomized Phase III study of doxorubicin versus cisplatin/interferon alpha-2b/Docorubicin/Fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma

AU - Yeo, W

AU - Mok, TS

AU - Zee, B

AU - Leung, TWT

AU - Lai, PBS

AU - Lau, WY

AU - Koh, J

AU - Mo, FKF

AU - Yu, SCH

AU - Chan, AT

AU - Hui, P

AU - Ma, B

AU - Lam, KC

AU - Ho, WM

AU - Wong, HT

AU - Tang, A

AU - Johnson, Philip

PY - 2005/10/19

Y1 - 2005/10/19

UR - http://www.scopus.com/inward/record.url?scp=27144557565&partnerID=8YFLogxK

U2 - 10.1093/jnci/dji315

DO - 10.1093/jnci/dji315

M3 - Article

C2 - 16234567

SN - 1460-2105

VL - 97

SP - 1532

EP - 1538

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

ER -